@article{article, title  = {{Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.}},

 publisher = {{Springer Verlag}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/117002 https://doi.org/10.1007/s40273-017-0521-5 }},

 year = {{2017}},

 month = {{11}},

 author = {{Bermejo I and Stevenson M and Archer R and Stevens JW and Goka E and Clowes M and Scott DL and Young A}},

 doi = {{10.1007/s40273-017-0521-5}},

 volume = {{35}},

 journal = {{Pharmacoeconomics}},

 issue = {{11}},

 pages = {{1141-1151}},

 note = {{Accessed on 2025/11/05}}}